# Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

> **NCT00671671** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Hepatitis, Chronic
- Hepatitis C Virus

## Interventions

- **DRUG:** Small Molecule Agent (PF-868554)
- **DRUG:** Small Molecule Agent (PF-868554)

## Key facts

- **NCT ID:** NCT00671671
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671671, "Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00671671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*